The Center for Pharmaceutical Product Safety of Uzbekistan held discussions on regulatory interaction issues in the pharmaceutical sector between Uzbekistan and Saudi Arabia. Aspects such as drug registration and certification were discussed.
The Center for Pharmaceutical Product Safety of Uzbekistan held discussions on regulatory interaction issues in the pharmaceutical sector between Uzbekistan and Saudi Arabia. Aspects such as drug registration and certification were discussed.
As part of the meeting, the Center for Pharmaceutical Product Safety gathered representatives from pharmaceutical companies from Saudi Arabia and India. The parties examined in detail procedures related to the circulation of medicines in Uzbekistan, including state registration, recognition procedure registration, certification, documentation submission, and expert evaluation.
Center specialists provided foreign companies with information about the current state registration procedure for medicines in Uzbekistan. For their part, representatives from Saudi Arabia stated their readiness to support further cooperation between the Center for Pharmaceutical Product Safety and the Saudi Food and Drug Authority (SFDA).
Participants emphasized the significance of SFDA's experience for improving the Center's activities in accordance with international standards. This includes work aimed at achieving the WHO's ML3 maturity level in the future. At the end of the meeting, the parties agreed to continue practical interaction, exchange experiences, and discuss emerging issues through working-level contacts.
Representatives of the Chamber of Commerce and Industry of Uzbekistan held negotiations with a delegation from the Turkish pharmaceutical company Kiperin İlaç Gıda Sanayi ve Ticaret Limited Şirketi. The goal of the meetings was to discuss opportunities for deepening interaction in the field of pharmaceuticals.
The negotiations included Bakhrum Makhatramov, Deputy Chairman of the Chamber of Commerce and Industry of Uzbekistan, Advisor to the Chairman Alisher Shaykhov, as well as Tolga Pektaş, CEO of the Turkish company. Issues regarding strengthening trade and economic partnership between Uzbekistan and Turkey were discussed.
Participants focused on implementing joint projects in the pharmaceutical industry, increasing investment cooperation, expanding import-export operations, and establishing direct ties between the business communities of both countries.
Information about the investment climate of Uzbekistan and opportunities for localizing production was presented to representatives of the Turkish firm. Existing state support measures for investors, tax and customs benefits, as well as conditions for foreign trade operations were outlined.
Following the discussions, the parties reached an agreement on further joint work on practical pharmaceutical projects. Furthermore, it was decided to promote technology transfer and investments, as well as strengthen business ties between entrepreneurs from Uzbekistan and Turkey.
Kiperin İlaç Gıda Sanayi ve Ticaret Limited Şirketi was founded in 2019 and specializes in the production of vitamins, collagen, food additives, and other health products. The company's products are manufactured in accordance with international GMP, HACCP, ISO, and Halal standards and are exported to many foreign countries.
A meeting took place in Tashkent, Uzbekistan, between Uzbekistan and the Japan International Cooperation Agency (JICA). During this meeting, new areas for practical interaction in medicine and pharmaceuticals were discussed at the Pharmaceutical Industry Development Agency.
The Agency Director, Abdullah Azizov, presented the Japanese side with information on the current reforms in Uzbekistan's pharmaceutical sector. He highlighted measures aimed at stimulating domestic production, attracting investment, implementing innovations, and expanding international partnerships.
Information was also provided about the agency's experience in joint work with foreign partners in areas such as technology transfer, scientific research, staff training, and the implementation of investment projects. JICA representatives indicated technical assistance in healthcare and pharmaceuticals, as well as opportunities for knowledge and experience exchange, and joint projects for specialists.
As a result of the meeting, the parties reached an agreement to expand practical cooperation between Uzbekistan and Japan. It was decided to implement joint initiatives and develop innovative projects in the medical and pharmaceutical sectors.
